3 completed, 1 unknown. 2 Phase 3, 1 Not applicable.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 2 | Completed 2 |
| Not applicable | 1 | Completed 1 |
Follow Ethypharm: new trials by email
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Baclocur® Post-Authorisation Safety Study in Real-life Settings in France Baclofen Tablets - Alcohol Use Disorder | Unknown | Ethypharm | 975 | 2020-12-22 | 2021-01-05 | |
| Agitation and Aggressivity in Alzheimer's Disease Patients: A Cohort Study NeuroPsychiatric Inventory Clinician (NPI-C) - Alzheimer Disease | Not applicable | Completed | University Hospital, Toulouse | 270 | 2014-11-01 | 2021-10-14 |
| Efficacy and Safety of Baclofen for Maintenance of Abstinence in Alcohol Dependent Patients Baclofen, Placebo (for baclofen) - Alcohol Dependence | Phase 3 | Completed | Ethypharm | 316 | 2012-12-01 | 2014-07-30 |
| Efficacy and Safety of Fentanyl ETHYPHARM for Breakthrough Pain in Opioid-treated Patients With Cancer Fentanyl Ethypharm - Breakthrough Pain, Cancer | Phase 3 | Completed | Ethypharm | 91 | 2011-11-01 | 2013-05-03 |
Alcoholism (2) · Alzheimer Disease (1) · Breakthrough Pain (1) · Neoplasms (1) · Psychomotor Agitation (1)
Baclofen (2)
France (3) · Czechia (1)
Henri-Jean Aubin, MD, Ph.D (1)